This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamada, S. Articles by Teramoto, A. Search for Related Content PubMed PubMed Citation Articles by Yamada, S. Articles by Teramoto, A.

Inactivation of the Tumor Suppressor Gene on 11q13 in Brothers with Familial Acrogigantism without Multiple Endocrine Neoplasia Type 1¹

Department of Neurosurgery (S.Y., K.T., M.U.), Toranomon Hospital, Tokyo; Otsuka Department of Clinical and Molecular Nutrition (K.Y., M.I.), and Department of Pathology (T.S.), School of Medicine, The University of Tokushima, Tokushima; Department of Neurosurgery (A.T.), Nihon Medical University, Tokyo, Japan.

Address correspondence and requests for reprints to Dr. Shozo Yamada at: Department of Neurosurgery, Toranomon Hospital, 2–2-2, Toranomon, Minato-ku, Tokyo, 105, Japan.

Two of three brothers (the second and third brothers) and their uncle (their mother’s brother) presented acrogigantism without multiple endocrine neoplasia type 1 (MEN 1). An invasive macroadenoma was found in the second brother, and it was histologically confirmed as a sparsely granulated GH cell adenoma. Two distinct microadenomas were found in the third brother, and these were histologically diagnosed as a mixed GH cell and PRL cell adenoma and a sparsely granulated GH cell adenoma, respectively. The loss of heterozygosity (LOH) was analyzed in two adenomas (GH cell adenoma from the second brother and a mixed GH cell and PRL cell adenoma from the third brother) by determining microsatellite polymorphisms of DNAs from tumors and patients’ leukocytes. The LOH was found on the chromosome 11q13, whereas LOH was not detected on 1p31-36, 2p, 3p, 4, 5, 6p, 7, 8, 9p21-22, 12p, and 19q13 in both pituitary adenomas examined. The haplotype analysis showed that the same haplotype on 11q13 was found in their mother and the unaffected first brother as well as in the affected uncle and two brothers. The deleted alleles on chromosome 11q13 in the tumors of two affected brothers were, however, restricted to those transmitted from their unaffected father. These data suggest that inactivation of the MEN 1 gene or other tumor suppressor genes on chromosome 11q13 plays an important role for the development of our familial acrogigantism without MEN 1.

This article has been cited by other articles:

				C. A. Leontiou, M. Gueorguiev, J. van der Spuy, R. Quinton, F. Lolli, S. Hassan, H. S. Chahal, S. C. Igreja, S. Jordan, J. Rowe, et al. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2390 - 2401. [Abstract] [Full Text] [PDF]

				O. Vierimaa, M. Georgitsi, R. Lehtonen, P. Vahteristo, A. Kokko, A. Raitila, K. Tuppurainen, T. M. L. Ebeling, P. I. Salmela, R. Paschke, et al. Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene. Science, May 26, 2006; 312(5777): 1228 - 1230. [Abstract] [Full Text] [PDF]

				B. S. Soares, K. Eguchi, and L. A. Frohman Tumor Deletion Mapping on Chromosome 11q13 in Eight Families with Isolated Familial Somatotropinoma and in 15 Sporadic Somatotropinomas J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6580 - 6587. [Abstract] [Full Text] [PDF]

				B. H. Jorge, S. K. Agarwal, V. S. Lando, R. Salvatori, R. R. Barbero, N. Abelin, M. A. Levine, S. J. Marx, and S. P. A. Toledo Study of the Multiple Endocrine Neoplasia Type 1, Growth Hormone-Releasing Hormone Receptor, Gs{{alpha}}, and Gi2{{alpha}} Genes in Isolated Familial Acromegaly J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 542 - 544. [Abstract] [Full Text]

				M. R. Gadelha, K. Rhode, R. D. Kineman, and L. A. Frohman Authors' Response: Isolated Familial Somatotropinomas: Does the Disease Map to 11q13 or to 2p16? J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4921 - 4921. [Full Text]

				T. Abe, K. Yoshimoto, M. Taniyama, K. Hanakawa, H. Izumiyama, M. Itakura, and K. Matsumoto An Unusual Kindred of the Multiple Endocrine Neoplasia Type 1 (MEN1) in Japanese J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1327 - 1330. [Full Text]

				M. R. Gadelha, K. N. Une, K. Rohde, M. Vaisman, R. D. Kineman, and L. A. Frohman Isolated Familial Somatotropinomas: Establishment of Linkage to Chromosome 11q13.1-11q13.3 and Evidence for a Potential Second Locus at Chromosome 2p16-12 J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 707 - 714. [Abstract] [Full Text]

				M. R. Gadelha, T. R. Prezant, K. N. Une, R. P. Glick, S. F. Moskal II, M. Vaisman, S. Melmed, R. D. Kineman, and L. A. Frohman Loss of Heterozygosity on Chromosome 11q13 in Two Families with Acromegaly/Gigantism Is Independent of Mutations of the Multiple Endocrine Neoplasia Type I Gene J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 249 - 256. [Abstract] [Full Text]

				B. T. Teh, S. Kytölä, F. Farnebo, L. Bergman, F. K. Wong, G. Weber, N. Hayward, C. Larsson, B. Skogseid, A. Beckers, et al. Mutation Analysis of the MEN1 Gene in Multiple Endocrine Neoplasia Type 1, Familial Acromegaly and Familial Isolated Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2621 - 2626. [Abstract] [Full Text]

				C. Tanaka, K. Yoshimoto, S. Yamada, H. Nishioka, S. Ii, M. Moritani, T. Yamaoka, and M. Itakura Absence of Germ-Line Mutations of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene in Familial Pituitary Adenoma in Contrast to MEN1 in Japanese J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 960 - 965. [Abstract] [Full Text]